Celularity Pfcf Ratio vs Roe Analysis

CELU Stock

USD 2.76 0.09 3.16%

Celularity financial indicator trend analysis is way more than just evaluating Celularity prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Celularity is a good investment. Please check the relationship between Celularity Pfcf Ratio and its Roe accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Pfcf Ratio vs Roe

Pfcf Ratio vs Roe Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Celularity Pfcf Ratio account and Roe. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Celularity's Pfcf Ratio and Roe is -0.51. Overlapping area represents the amount of variation of Pfcf Ratio that can explain the historical movement of Roe in the same time period over historical financial statements of Celularity, assuming nothing else is changed. The correlation between historical values of Celularity's Pfcf Ratio and Roe is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pfcf Ratio of Celularity are associated (or correlated) with its Roe. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Roe has no effect on the direction of Pfcf Ratio i.e., Celularity's Pfcf Ratio and Roe go up and down completely randomly.

Correlation Coefficient

-0.51

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Pfcf Ratio

Roe

Most indicators from Celularity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Celularity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.Tax Provision is likely to gain to about 10.5 K in 2024, whereas Selling General Administrative is likely to drop slightly above 48.1 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	159.7M	146.6M	99.3M	108.8M
Cost Of Revenue	9.7M	19.7M	16.0M	12.4M

Total Operating Expenses Cost Of Revenue

Celularity fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Property Plant And Equipment Net	Warrants
Total Assets		0.61	0.82	0.54	-0.08	-0.33	0.76	0.22	-0.68	0.22	0.8	1.0	-0.18	0.88	0.8	0.46	0.89	0.59	0.69	0.56	0.74	0.83	0.27	0.88	0.81	-0.7
Short Long Term Debt Total	0.61		0.46	0.97	0.16	-0.91	0.8	0.77	-0.92	0.66	0.23	0.61	0.03	0.85	0.54	0.85	0.84	0.56	0.39	0.94	0.32	0.6	0.07	0.87	0.8	-0.91
Other Current Liab	0.82	0.46		0.52	-0.41	-0.3	0.83	0.01	-0.66	0.19	0.87	0.78	0.35	0.59	0.83	0.52	0.61	0.5	0.87	0.39	0.84	0.9	-0.28	0.67	0.82	-0.68
Total Current Liabilities	0.54	0.97	0.52		0.07	-0.94	0.84	0.72	-0.95	0.7	0.24	0.52	0.26	0.75	0.55	0.9	0.75	0.58	0.43	0.93	0.32	0.62	-0.17	0.81	0.82	-0.94
Total Stockholder Equity	-0.08	0.16	-0.41	0.07		-0.35	-0.37	0.64	0.08	0.07	-0.59	-0.02	-0.41	0.02	-0.54	-0.14	0.06	0.2	-0.43	0.36	-0.73	-0.53	0.42	0.0	-0.19	0.13
Other Liab	-0.33	-0.91	-0.3	-0.94	-0.35		-0.63	-0.86	0.82	-0.7	0.05	-0.34	-0.24	-0.59	-0.27	-0.8	-0.6	-0.55	-0.21	-0.93	0.0	-0.34	0.16	-0.65	-0.64	0.79
Net Tangible Assets	0.76	0.8	0.83	0.84	-0.37	-0.63		0.28	-0.94	0.57	0.71	0.72	0.34	0.8	0.9	0.84	0.79	0.6	0.68	0.7	0.77	0.94	-0.25	0.86	0.95	-0.95
Net Debt	0.22	0.77	0.01	0.72	0.64	-0.86	0.28		-0.5	0.39	-0.35	0.25	-0.2	0.49	-0.09	0.52	0.5	0.22	0.11	0.76	-0.28	0.02	0.25	0.49	0.32	-0.47
Retained Earnings	-0.68	-0.92	-0.66	-0.95	0.08	0.82	-0.94	-0.5		-0.75	-0.5	-0.66	-0.29	-0.83	-0.76	-0.89	-0.83	-0.74	-0.45	-0.9	-0.52	-0.78	0.19	-0.9	-0.93	1.0
Accounts Payable	0.22	0.66	0.19	0.7	0.07	-0.7	0.57	0.39	-0.75		0.1	0.2	0.35	0.5	0.38	0.84	0.53	0.66	-0.08	0.74	0.11	0.32	-0.28	0.6	0.48	-0.73
Cash	0.8	0.23	0.87	0.24	-0.59	0.05	0.71	-0.35	-0.5	0.1		0.76	0.17	0.56	0.91	0.3	0.56	0.47	0.67	0.16	0.94	0.89	-0.1	0.59	0.7	-0.53
Non Current Assets Total	1.0	0.61	0.78	0.52	-0.02	-0.34	0.72	0.25	-0.66	0.2	0.76		-0.23	0.88	0.76	0.43	0.89	0.59	0.66	0.56	0.7	0.79	0.32	0.88	0.78	-0.67
Non Currrent Assets Other	-0.18	0.03	0.35	0.26	-0.41	-0.24	0.34	-0.2	-0.29	0.35	0.17	-0.23		-0.26	0.23	0.35	-0.24	0.28	0.15	0.1	0.15	0.24	-0.99	-0.09	0.28	-0.29
Other Assets	0.88	0.85	0.59	0.75	0.02	-0.59	0.8	0.49	-0.83	0.5	0.56	0.88	-0.26		0.73	0.69	1.0	0.57	0.5	0.76	0.59	0.75	0.36	0.98	0.8	-0.84
Cash And Short Term Investments	0.8	0.54	0.83	0.55	-0.54	-0.27	0.9	-0.09	-0.76	0.38	0.91	0.76	0.23	0.73		0.57	0.72	0.6	0.6	0.46	0.92	0.97	-0.15	0.77	0.88	-0.79
Net Receivables	0.46	0.85	0.52	0.9	-0.14	-0.8	0.84	0.52	-0.89	0.84	0.3	0.43	0.35	0.69	0.57		0.71	0.5	0.43	0.77	0.42	0.62	-0.27	0.78	0.7	-0.9
Common Stock Total Equity	0.89	0.84	0.61	0.75	0.06	-0.6	0.79	0.5	-0.83	0.53	0.56	0.89	-0.24	1.0	0.72	0.71		0.6	0.5	0.78	0.58	0.74	0.34	0.99	0.79	-0.84
Inventory	0.59	0.56	0.5	0.58	0.2	-0.55	0.6	0.22	-0.74	0.66	0.47	0.59	0.28	0.57	0.6	0.5	0.6		0.06	0.76	0.27	0.51	-0.18	0.66	0.74	-0.72
Other Current Assets	0.69	0.39	0.87	0.43	-0.43	-0.21	0.68	0.11	-0.45	-0.08	0.67	0.66	0.15	0.5	0.6	0.43	0.5	0.06		0.19	0.76	0.76	-0.11	0.53	0.6	-0.49
Other Stockholder Equity	0.56	0.94	0.39	0.93	0.36	-0.93	0.7	0.76	-0.9	0.74	0.16	0.56	0.1	0.76	0.46	0.77	0.78	0.76	0.19		0.14	0.48	0.0	0.81	0.77	-0.87
Total Liab	0.74	0.32	0.84	0.32	-0.73	0.0	0.77	-0.28	-0.52	0.11	0.94	0.7	0.15	0.59	0.92	0.42	0.58	0.27	0.76	0.14		0.93	-0.09	0.61	0.69	-0.57
Total Current Assets	0.83	0.6	0.9	0.62	-0.53	-0.34	0.94	0.02	-0.78	0.32	0.89	0.79	0.24	0.75	0.97	0.62	0.74	0.51	0.76	0.48	0.93		-0.15	0.79	0.9	-0.81
Common Stock	0.27	0.07	-0.28	-0.17	0.42	0.16	-0.25	0.25	0.19	-0.28	-0.1	0.32	-0.99	0.36	-0.15	-0.27	0.34	-0.18	-0.11	0.0	-0.09	-0.15		0.2	-0.18	0.19
Property Plant Equipment	0.88	0.87	0.67	0.81	0.0	-0.65	0.86	0.49	-0.9	0.6	0.59	0.88	-0.09	0.98	0.77	0.78	0.99	0.66	0.53	0.81	0.61	0.79	0.2		0.85	-0.9
Property Plant And Equipment Net	0.81	0.8	0.82	0.82	-0.19	-0.64	0.95	0.32	-0.93	0.48	0.7	0.78	0.28	0.8	0.88	0.7	0.79	0.74	0.6	0.77	0.69	0.9	-0.18	0.85		-0.93
Warrants	-0.7	-0.91	-0.68	-0.94	0.13	0.79	-0.95	-0.47	1.0	-0.73	-0.53	-0.67	-0.29	-0.84	-0.79	-0.9	-0.84	-0.72	-0.49	-0.87	-0.57	-0.81	0.19	-0.9	-0.93

Click cells to compare fundamentals

Celularity Account Relationship Matchups

Celularity fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	291.6M	431.0M	414.1M	401.1M	143.9M	136.7M
Short Long Term Debt Total	28.1M	30.6M	31.1M	65.6M	75.4M	79.2M
Other Current Liab	(3.5M)	18.3M	11.7M	16.4M	2.4M	2.3M
Total Current Liabilities	229.1K	26.7M	26.2M	62.1M	67.3M	70.7M
Total Stockholder Equity	263.4M	(531.4M)	99.4M	198.9M	41.0M	43.0M
Other Liab	334.9M	358.0M	260.4M	112.1M	100.9M	95.8M
Net Tangible Assets	(726.0M)	214.1M	(147.1M)	(41.8M)	(48.1M)	(50.5M)
Net Debt	27.1M	(23.7M)	(6.1M)	51.6M	39.0M	41.0M
Retained Earnings	3.9M	(563.6M)	(663.7M)	(645.5M)	(841.8M)	(799.7M)
Accounts Payable	3.7M	5.4M	9.3M	5.8M	14.1M	8.0M
Cash	917.0K	54.3M	37.2M	14.0M	227K	215.7K
Non Current Assets Total	290.6M	358.8M	376.9M	367.6M	124.1M	117.9M
Non Currrent Assets Other	(464.9M)	20.1M	39.8M	23.3M	26.9M	28.3M
Cash And Short Term Investments	917.0K	54.3M	37.2M	14.0M	16.1M	23.4M
Net Receivables	3.1M	6.6M	5.2M	7.0M	10.0M	6.6M
Liabilities And Stockholders Equity	291.6M	431.0M	414.1M	401.1M	461.2M	338.4M
Inventory	3.2M	3.9M	9.5M	5.3M	5.8M	5.7M
Other Current Assets	92.2K	7.4M	2K	7.3M	329K	312.6K
Other Stockholder Equity	259.5M	32.2M	763.1M	844.4M	971.0M	1.0B
Total Liab	28.2M	962.4M	314.7M	202.2M	102.9M	97.8M
Total Current Assets	1.0M	72.2M	37.2M	33.5M	19.8M	30.0M
Common Stock	258.4M	1K	12K	15K	13.5K	12.8K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Celularity Pfcf Ratio vs Roe Analysis

Pfcf Ratio vs Roe

Pfcf Ratio vs Roe Correlation Analysis

Correlation Coefficient

Pfcf Ratio

Roe

Celularity fundamental ratios Correlations

Celularity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Celularity fundamental ratios Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Celularity Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Warrants	+ 1.0	Retained Earnings
Common Stock Total Equity	+ 1.0	Other Assets
Property Plant Equipment	+ 0.99	Common Stock Total Equity
Property Plant Equipment	+ 0.98	Other Assets
Total Current Liabilities	+ 0.97	Short Long Term Debt Total

Common Stock	- 0.99	Non Currrent Assets Other
Warrants	- 0.95	Net Tangible Assets
Retained Earnings	- 0.95	Total Current Liabilities
Retained Earnings	- 0.94	Net Tangible Assets
Warrants	- 0.94	Total Current Liabilities
Other Liab	- 0.94	Total Current Liabilities